220 related articles for article (PubMed ID: 31442917)
1. Targeting c-MYC through Interference with NAMPT and SIRT1 and Their Association to Oncogenic Drivers in Murine Serrated Intestinal Tumorigenesis.
Brandl L; Zhang Y; Kirstein N; Sendelhofert A; Boos SL; Jung P; Greten F; Rad R; Menssen A
Neoplasia; 2019 Oct; 21(10):974-988. PubMed ID: 31442917
[TBL] [Abstract][Full Text] [Related]
2. The c-MYC/NAMPT/SIRT1 feedback loop is activated in early classical and serrated route colorectal cancer and represents a therapeutic target.
Brandl L; Kirstein N; Neumann J; Sendelhofert A; Vieth M; Kirchner T; Menssen A
Med Oncol; 2018 Nov; 36(1):5. PubMed ID: 30460421
[TBL] [Abstract][Full Text] [Related]
3. The c-MYC oncoprotein, the NAMPT enzyme, the SIRT1-inhibitor DBC1, and the SIRT1 deacetylase form a positive feedback loop.
Menssen A; Hydbring P; Kapelle K; Vervoorts J; Diebold J; Lüscher B; Larsson LG; Hermeking H
Proc Natl Acad Sci U S A; 2012 Jan; 109(4):E187-96. PubMed ID: 22190494
[TBL] [Abstract][Full Text] [Related]
4. Expression of n-MYC, NAMPT and SIRT1 in Basal Cell Carcinomas and their Cells of Origin.
Brandl L; Hartmann D; Kirchner T; Menssen A
Acta Derm Venereol; 2019 Jan; 99(1):63-71. PubMed ID: 30182136
[TBL] [Abstract][Full Text] [Related]
5. Diet-induced obesity promotes murine gastric cancer growth through a nampt/sirt1/c-myc positive feedback loop.
Li HJ; Che XM; Zhao W; He SC; Zhang ZL; Chen R; Fan L; Jia ZL
Oncol Rep; 2013 Nov; 30(5):2153-60. PubMed ID: 23970286
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer.
Kriegl L; Vieth M; Kirchner T; Menssen A
Oncotarget; 2012 Oct; 3(10):1182-93. PubMed ID: 23045412
[TBL] [Abstract][Full Text] [Related]
7.
Lucena-Cacace A; Otero-Albiol D; Jiménez-García MP; Muñoz-Galvan S; Carnero A
Clin Cancer Res; 2018 Mar; 24(5):1202-1215. PubMed ID: 29203587
[No Abstract] [Full Text] [Related]
8. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract][Full Text] [Related]
9. Nicotinamide Phosphoribosyltransferase (NAMPT) as a Therapeutic Target in BRAF-Mutated Metastatic Melanoma.
Audrito V; Managò A; La Vecchia S; Zamporlini F; Vitale N; Baroni G; Cignetto S; Serra S; Bologna C; Stingi A; Arruga F; Vaisitti T; Massi D; Mandalà M; Raffaelli N; Deaglio S
J Natl Cancer Inst; 2018 Mar; 110(3):. PubMed ID: 29309612
[TBL] [Abstract][Full Text] [Related]
10. The NAMPT/E2F2/SIRT1 axis promotes proliferation and inhibits p53-dependent apoptosis in human melanoma cells.
Zhao H; Tang W; Chen X; Wang S; Wang X; Xu H; Li L
Biochem Biophys Res Commun; 2017 Nov; 493(1):77-84. PubMed ID: 28919418
[TBL] [Abstract][Full Text] [Related]
11. Tumors carrying BRAF-mutations over-express NAMPT that is genetically amplified and possesses oncogenic properties.
Audrito V; Moiso E; Ugolini F; Messana VG; Brandimarte L; Manfredonia I; Bianchi S; De Logu F; Nassini R; Szumera-Ciećkiewicz A; Taverna D; Massi D; Deaglio S
J Transl Med; 2022 Mar; 20(1):118. PubMed ID: 35272691
[TBL] [Abstract][Full Text] [Related]
12. Nicotinamide phosphoribosyl transferase regulates cell growth via the Sirt1/P53 signaling pathway and is a prognosis marker in colorectal cancer.
Pan JH; Zhou H; Zhu SB; Huang JL; Zhao XX; Ding H; Qin L; Pan YL
J Cell Physiol; 2019 Apr; 234(4):4385-4395. PubMed ID: 30191976
[TBL] [Abstract][Full Text] [Related]
13. Myc-Driven Glycolysis Is a Therapeutic Target in Glioblastoma.
Tateishi K; Iafrate AJ; Ho Q; Curry WT; Batchelor TT; Flaherty KT; Onozato ML; Lelic N; Sundaram S; Cahill DP; Chi AS; Wakimoto H
Clin Cancer Res; 2016 Sep; 22(17):4452-65. PubMed ID: 27076630
[TBL] [Abstract][Full Text] [Related]
14. Sirt1 deacetylates c-Myc and promotes c-Myc/Max association.
Mao B; Zhao G; Lv X; Chen HZ; Xue Z; Yang B; Liu DP; Liang CC
Int J Biochem Cell Biol; 2011 Nov; 43(11):1573-81. PubMed ID: 21807113
[TBL] [Abstract][Full Text] [Related]
15. SIRT1 promotes N-Myc oncogenesis through a positive feedback loop involving the effects of MKP3 and ERK on N-Myc protein stability.
Marshall GM; Liu PY; Gherardi S; Scarlett CJ; Bedalov A; Xu N; Iraci N; Valli E; Ling D; Thomas W; van Bekkum M; Sekyere E; Jankowski K; Trahair T; Mackenzie KL; Haber M; Norris MD; Biankin AV; Perini G; Liu T
PLoS Genet; 2011 Jun; 7(6):e1002135. PubMed ID: 21698133
[TBL] [Abstract][Full Text] [Related]
16. c-MYC and SIRT1 locked in a vicious cycle.
Menssen A; Hermeking H
Oncotarget; 2012 Feb; 3(2):112-3. PubMed ID: 22337808
[No Abstract] [Full Text] [Related]
17. Ectopic expression of miR-494 inhibited the proliferation, invasion and chemoresistance of pancreatic cancer by regulating SIRT1 and c-Myc.
Liu Y; Li X; Zhu S; Zhang JG; Yang M; Qin Q; Deng SC; Wang B; Tian K; Liu L; Niu Y; Wang CY; Zhao G
Gene Ther; 2015 Sep; 22(9):729-38. PubMed ID: 25965392
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone II A inhibits tat-induced HIV-1 transactivation through redox-regulated AMPK/Nampt pathway.
Zhang HS; Chen XY; Wu TC; Zhang FJ
J Cell Physiol; 2014 Sep; 229(9):1193-201. PubMed ID: 24414799
[TBL] [Abstract][Full Text] [Related]
19. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas.
Jang KY; Noh SJ; Lehwald N; Tao GZ; Bellovin DI; Park HS; Moon WS; Felsher DW; Sylvester KG
PLoS One; 2012; 7(9):e45119. PubMed ID: 23024800
[TBL] [Abstract][Full Text] [Related]
20. MYC and RAF: Key Effectors in Cellular Signaling and Major Drivers in Human Cancer.
Stefan E; Bister K
Curr Top Microbiol Immunol; 2017; 407():117-151. PubMed ID: 28466200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
